275 related articles for article (PubMed ID: 36414219)
1. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
3. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
4. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.
Valenti L; Griffini S; Lamorte G; Grovetti E; Uceda Renteria SC; Malvestiti F; Scudeller L; Bandera A; Peyvandi F; Prati D; Meroni P; Cugno M
J Autoimmun; 2021 Feb; 117():102595. PubMed ID: 33453462
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Plasma 25(OH)D
Alabdullatif W; Almnaizel A; Alhijji A; Alshathri A; Albarrag A; Bindayel I
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111039
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
[TBL] [Abstract][Full Text] [Related]
8. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
9. Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.
Rajamanickam A; Venkataraman A; Kumar NP; Sasidaran R; Pandiarajan AN; Selvaraj N; Mittal R; Gowshika K; Putlibai S; Lakshan Raj S; Ramanan PV; Babu S
BMC Pediatr; 2023 Apr; 23(1):156. PubMed ID: 37013538
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
Smail SW; Babaei E; Amin K; Abdulahad WH
Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
[TBL] [Abstract][Full Text] [Related]
11. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
Front Immunol; 2021; 12():716361. PubMed ID: 34491250
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
[TBL] [Abstract][Full Text] [Related]
13. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
[TBL] [Abstract][Full Text] [Related]
14. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
[TBL] [Abstract][Full Text] [Related]
15. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Front Immunol; 2021; 12():663187. PubMed ID: 33841446
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure.
Keller GA; Colaianni I; Coria J; Di Girolamo G; Miranda S
Respir Med; 2023 Apr; 209():107155. PubMed ID: 36796547
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
Med Clin (Engl Ed); 2021 Apr; 156(7):324-331. PubMed ID: 33824908
[TBL] [Abstract][Full Text] [Related]
18. Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy.
Hetland G; Fagerhol MK; Mirlashari MR; Nissen-Meyer LSH; Croci S; Lonati PA; Bonacini M; Salvarani C; Marvisi C; Bodio C; Muratore F; Borghi MO; Meroni PL
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672123
[TBL] [Abstract][Full Text] [Related]
19. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin participates in platelet activation in COVID-19 patients.
Lupia E; Capuano M; Vizio B; Schiavello M; Bosco O; Gelardi M; Favale E; Pivetta E; Morello F; Husain S; Keshavjee S; Del Sorbo L; Montrucchio G
EBioMedicine; 2022 Nov; 85():104305. PubMed ID: 36242922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
